Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
HIMS 
Hims Hers Health Inc (HIMS)
Top performer
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/11/2025: HIMS (5-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
13 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $49.45
1 Year Target Price $49.45
| 4 | Strong Buy |
| 1 | Buy |
| 6 | Hold |
| 1 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 148.21% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 09/11/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 11.27B USD | Price to earnings Ratio 60.89 | 1Y Target Price 49.45 |
Price to earnings Ratio 60.89 | 1Y Target Price 49.45 | ||
Volume (30-day avg) 13 | Beta 2.14 | 52 Weeks Range 15.73 - 72.98 | Updated Date 09/12/2025 |
52 Weeks Range 15.73 - 72.98 | Updated Date 09/12/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.85 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 9.61% | Operating Margin (TTM) 4.91% |
Management Effectiveness
Return on Assets (TTM) 6.94% | Return on Equity (TTM) 41.88% |
Valuation
Trailing PE 60.89 | Forward PE 62.11 | Enterprise Value 10698988579 | Price to Sales(TTM) 5.59 |
Enterprise Value 10698988579 | Price to Sales(TTM) 5.59 | ||
Enterprise Value to Revenue 5.31 | Enterprise Value to EBITDA 69.13 | Shares Outstanding 217642000 | Shares Floating 197565976 |
Shares Outstanding 217642000 | Shares Floating 197565976 | ||
Percent Insiders 10.63 | Percent Institutions 88.99 |
Upturn AI SWOT
Hims Hers Health Inc
Company Overview
History and Background
Hims & Hers Health, Inc. was founded in 2017. Initially focused on men's health (Hims), it expanded to women's health (Hers) and broadened its offerings to include various telehealth services.
Core Business Areas
- Telehealth Services: Provides access to licensed healthcare professionals via online consultations for various conditions.
- Prescription Medications: Offers prescription medications for conditions like hair loss, erectile dysfunction, acne, and mental health, fulfilled through partner pharmacies.
- Over-the-Counter Products: Sells over-the-counter products related to sexual health, hair care, skincare, and wellness.
Leadership and Structure
Andrew Dudum is the CEO. The company has a typical corporate structure with departments for marketing, technology, operations, and finance.
Top Products and Market Share
Key Offerings
- Hair Loss Treatments (Hims & Hers): Offers Finasteride, Minoxidil, and other hair loss solutions. The market is competitive, with brands like Rogaine and Keeps, but Hims & Hers focuses on online convenience. Market Share data is not readily available, but Hims & Hers is a significant player. Competitors include Keeps, Roman, Rogaine.
- Erectile Dysfunction (Hims): Sells Sildenafil (generic Viagra) and other ED medications. This is a major revenue driver. Competitors include Roman, BlueChew, Viagra (Pfizer).
- Mental Health Services (Hims & Hers): Provides online therapy and psychiatric services, including medication management for conditions like anxiety and depression. Competitors include Talkspace, BetterHelp, Cerebral.
- Skincare (Hers): Offers customized skincare products and treatments for acne and other skin concerns. Competitors include Curology, Apostrophe, and traditional skincare brands.
Market Dynamics
Industry Overview
The telehealth industry is experiencing rapid growth, driven by increased access to technology and a growing acceptance of remote healthcare. The rise of customized health solutions is another trend.
Positioning
Hims & Hers positions itself as a convenient and affordable online provider of healthcare and wellness products. Its competitive advantages include direct-to-consumer marketing, a subscription-based model, and a focus on personalized solutions.
Total Addressable Market (TAM)
The TAM for telehealth and personalized health is estimated to be in the hundreds of billions of dollars. Hims & Hers is positioned to capture a significant portion of this market through its diverse offerings and online platform.
Upturn SWOT Analysis
Strengths
- Strong brand recognition among millennials and Gen Z
- Direct-to-consumer business model
- Subscription-based revenue
- Broad product portfolio
- Strong online presence
Weaknesses
- Reliance on partner pharmacies
- Potential for regulatory scrutiny
- Marketing costs are high
- Customer acquisition costs are high
- Profitability concerns
Opportunities
- Expanding into new markets (international)
- Developing new product lines
- Partnerships with healthcare providers
- Increasing telehealth adoption
- Offering more personalized treatments
Threats
- Increased competition
- Changes in regulations
- Data security breaches
- Negative publicity
- Economic downturn
Competitors and Market Share
Key Competitors
- TDOC
- AMZN
- CERE
Competitive Landscape
Hims & Hers competes with established telehealth providers and direct-to-consumer brands. Its advantages include its strong brand and focus on personalized solutions, but it faces challenges from larger, more established competitors.
Growth Trajectory and Initiatives
Historical Growth: Hims & Hers has experienced rapid revenue growth in recent years, driven by increased customer acquisition and product expansion.
Future Projections: Analysts project continued revenue growth for Hims & Hers, but profitability remains a key concern.
Recent Initiatives: Recent initiatives include expanding into new markets, launching new products, and investing in technology and marketing.
Summary
Hims & Hers has a strong brand, especially among younger demographics, and offers a convenient online platform for healthcare and wellness. However, the company is not yet profitable and faces intense competition. Its growth depends on continued customer acquisition and successful expansion into new markets and products. Maintaining customer loyalty amidst rising marketing costs will be vital.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share data is approximate and based on available information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Hims Hers Health Inc
Exchange NYSE | Headquaters San Francisco, CA, United States | ||
IPO Launch date 2019-09-13 | Co-Founder, Chairman & CEO Mr. Andrew Dudum | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 1637 | Website https://www.hims.com |
Full time employees 1637 | Website https://www.hims.com | ||
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.